Skip to main content
Year archive

IL DONG PHARMACEUTICAL CO., LTD. — 2026 filings

All 21 regulatory filings released by IL DONG PHARMACEUTICAL CO., LTD. (249420) in 2026, sourced directly from the official regulator.

21 Filings
2026 Period
2026 filings (21)
Filing Released Lang
지속가능경영보고서등관련사항(자율공시)
Report Publication Announcement
2026-06-04 Korean
기업지배구조보고서공시
Governance Information
2026-05-29 Korean
분기보고서 (2026.03)
Interim / Quarterly Report Q1 2026
2026-05-15 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Q1 2026
2026-05-13 Korean
결산실적공시예고(안내공시)
Report Publication Announcement
2026-05-11 Korean
주주명부폐쇄기간또는기준일설정
Declaration of Voting Results & Voting Rights Announcements
2026-04-14 Korean
주요사항보고서(회사합병결정)
M&A Activity
2026-04-13 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2026-04-03 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information
2026-03-26 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2026-03-26 Korean
감사보고서제출
Audit Report / Information FY 2025
2026-03-18 Korean
사업보고서 (2025.12)
Annual Report FY 2025
2026-03-18 Korean
주주총회소집공고
AGM Information
2026-02-25 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2026-02-25 Korean
최대주주등소유주식변동신고서
Director's Dealing
2026-02-20 Korean
기업설명회(IR)개최(안내공시)
Investor Presentation
2026-02-20 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2026-02-20 Korean
결산실적공시예고(안내공시)
Report Publication Announcement
2026-02-10 Korean
[기재정정]타법인주식및출자증권처분결정
Capital/Financing Update
2026-02-06 Korean
매출액또는손익구조30%(대규모법인은15%)이상변경
Earnings Release FY 2025
2026-01-27 Korean
대표이사(대표집행임원)변경(안내공시)
Board/Management Information
2026-01-05 Korean